Takeda (TAK) Takeda's zasocitinib shows clear skin results in psoriasis trials

Go back to Takeda (TAK) Takeda's zasocitinib shows clear skin results in psoriasis trials
(NYSE: TAK) Delayed: 15.72 --0 (-0%)
Previous Close $15.72    52 Week High $0.55 
Open $15.72    52 Week Low $0.55 
Day High $15.72    P/E N/A 
Day Low $15.72    EPS $-0.20 
Volume 2,230